Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial-Reference-Cited by-同舟云学术

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial

Published:2012-01 Issue:1 Volume:13 Page:43-54
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Dearnaley David,Syndikus Isabel,Sumo Georges,Bidmead Margaret,Bloomfield David,Clark Catharine,Gao Annie,Hassan Shama,Horwich Alan,Huddart Robert,Khoo Vincent,Kirkbride Peter,Mayles Helen,Mayles Philip,Naismith Olivia,Parker Chris,Patterson Helen,Russell Martin,Scrase Christopher,South Chris,Staffurth John,Hall Emma

Funder

the Academic Radiotherapy Unit's Cancer Research UK programme

Cancer Research UK

Publisher

Elsevier BV

Subject

Oncology

Reference42 articles.

1. Biochemical outcome after radical prostatectomy, external beam radiation therapy or interstitial radiation therapy for clinically localised prostate cancer;D'Amico;JAMA,1998

2. Radiation therapy for clinically localised prostate cancer: a multi-institutional pooled analysis;Shipley;JAMA,1999

3. Survey of the availability and use of advanced radiotherapy technology in the UK;Mayles;Clin Oncol (R Coll Radiol),2010

4. Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials;Viani;Int J Radiat Oncol Biol Phys,2009

5. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue;Brenner;Int J Radiat Oncol Biol Phys,2002

Cited by 267 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypofractionated Dose Escalation Radiotherapy for High-risk Prostate Cancer: The Survival Analysis of the Prostate Cancer Study 5, a Groupe de Radio-oncologie Génito-urinaire du Quebec–led Phase 3 Trial;European Urology;2024-09

2. Enhancing treatment precision through radiobiological modeling for evaluating complex VMAT plans in prostate and head-and-neck cancers;Health and Technology;2024-08-19

3. Overview of Radiation Therapy in the Management of Localized and Metastatic Prostate Cancer;Current Urology Reports;2024-06-11

4. Rectal deformation management with IGRT in prostate radiotherapy: Can it be managed with rigid alignment alone?;Journal of Applied Clinical Medical Physics;2024-01-09

5. Hypofractionated, Dose Escalation Radiation Therapy for High-Risk Prostate Cancer: The Safety Analysis of the Prostate Cancer Study-5, a Groupe de Radio-Oncologie Génito-Urinaire de Quebec Led Phase 3 Trial;International Journal of Radiation Oncology*Biology*Physics;2024-01